These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26361157)

  • 1. Lipid Screening in Children.
    Daniels SR
    J Am Coll Cardiol; 2015 Sep; 66(11):1258-1260. PubMed ID: 26361157
    [No Abstract]   [Full Text] [Related]  

  • 2. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercholesterolemia in children: Why and how to screen for it?
    Girardet JP; Bocquet A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Rozé JC; Simeoni U; Turck D; Briend A; Dupont C;
    Arch Pediatr; 2018 Apr; 25(3):175-176. PubMed ID: 29548557
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial hypercholesterolemia. Proposed measures favoring systematic screening].
    Sabourin G
    Perspect Infirm; 2015; 12(3):14. PubMed ID: 26079033
    [No Abstract]   [Full Text] [Related]  

  • 7. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward.
    Santos RD; Frauches TS; Chacra AP
    J Atheroscler Thromb; 2015; 22(9):869-80. PubMed ID: 26194978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
    Turgeon RD; Barry AR; Pearson GJ
    Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining barriers to cascade screening for familial hypercholesterolemia in the United States.
    Andersen R; Andersen L
    J Clin Lipidol; 2016; 10(2):225-7. PubMed ID: 27055953
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for familial hypercholesterolaemia.
    Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial hypercholesterolemia: why screening, counselling and treatment should be integrated].
    Roeters van Lennep JE; Visseren FL; Jira PE
    Ned Tijdschr Geneeskd; 2015; 159():A8875. PubMed ID: 26013253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.
    Hopkins PN
    Curr Opin Lipidol; 2017 Apr; 28(2):136-143. PubMed ID: 28030379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cascade screening of familial hypercholesterolemia must go on.
    Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE
    Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyslipidemia - when are lipid lowering medications useful in clinical practice?].
    Blum MR; Stanga Z; Rodondi N
    Praxis (Bern 1994); 2013 May; 102(10):585-9. PubMed ID: 23644243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Essential Role of Primary Caregiver in Early Detection of Familial Hypercholesterolemia and Cardiovascular Prevention.
    St-Pierre J; Ruel I; Genest J
    Curr Pediatr Rev; 2017; 13(4):260-264. PubMed ID: 29473516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Family study of primary hypercholesterolemia in school children--the Tsukuba Study].
    Yanagi H; Hamaguchi H; Shimakura Y; Hirano C; Takita H; Tsuchiya S; Yoshiwara C
    Nihon Koshu Eisei Zasshi; 1990 Aug; 37(8):585-92. PubMed ID: 2132386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening children at immunisation visits can identify familial hypercholesterolaemia.
    Mayor S
    BMJ; 2016 Oct; 355():i5794. PubMed ID: 27789464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.